IL6 and colitis: The in vitro treatment of colonic biopsies from DSS-induced colitis mice with RvD2 (0.01, 0.1, and 0.3 μM) or anti-TNFα resulted in a significant downregulation of the pro-inflammatory cytokine transcripts TNFα and IL6, suggesting a marked attenuation of colonic inflammation.